YTHDF2 expression was increased in primary gliomas with higher WHO grade (Fig. 1A) and in IDH-wild-type gliomas (Fig. 1B) in the Microarray cohort (n = 301) of CGGA. This evidence concerns the gene YTHDF2 and central nervous system cancer.